PHOSPHORYLATION OF THE TAL1 ONCOPROTEIN BY THE EXTRACELLULAR-SIGNAL-REGULATED PROTEIN-KINASE ERK1

被引:76
作者
CHENG, JT
COBB, MH
BAER, R
机构
[1] UNIV TEXAS, SW MED CTR, DEPT MICROBIOL, 5323 HARRY HINES BLVD, DALLAS, TX 75235 USA
[2] UNIV TEXAS, SW MED CTR, DEPT PHARMACOL, DALLAS, TX 75235 USA
关键词
D O I
10.1128/MCB.13.2.801
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alteration of the TAL1 gene is the most common genetic lesion found in T-cell acute lymphoblastic leukemia. TALI encodes phosphoproteins, pp42TAL1 and pp22TAL1, that represent phosphorylated versions of the full-length (residues 1 to 331) and truncated (residues 176 to 331) TAL1 gene products, respectively. Both proteins contain the basic helix-loop-helix motif, a DNA-binding and protein dimerization motif common to several known transcriptional regulatory factors. We now report that serine residue 122 (S122) is a major phosphorylation site of pp42TAL1 in leukemic cell lines and transfected COS1 cells. In vivo phosphorylation of S122 is induced by epidermal growth factor with a rapid time course that parallels activation of the ERK/MAP2 protein kinases. Moreover, S122 is readily phosphorylated in vitro by the extracellular signal-regulated protein kinase ERK1. These data suggest that TAL1 residue S122 serves as an in vivo substrate for ERK/MAP2 kinases such as ERK1. Therefore, S122 phosphorylation may provide a mechanism whereby the properties of TAL1 polypeptides can be modulated by extracellular stimuli.
引用
收藏
页码:801 / 808
页数:8
相关论文
共 46 条
  • [1] ALVAREZ E, 1991, J BIOL CHEM, V266, P15277
  • [2] ANDERSSON S, 1989, J BIOL CHEM, V264, P8222
  • [3] BALL RL, 1990, J BIOL CHEM, V265, P12836
  • [4] THE GENE SCL IS EXPRESSED DURING EARLY HEMATOPOIESIS AND ENCODES A DIFFERENTIATION-RELATED DNA-BINDING MOTIF
    BEGLEY, CG
    APLAN, PD
    DENNING, SM
    HAYNES, BF
    WALDMANN, TA
    KIRSCH, IR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (24) : 10128 - 10132
  • [5] 2 DISTINCT MECHANISMS FOR THE SCL GENE ACTIVATION IN THE T(I-14) TRANSLOCATION OF T-CELL LEUKEMIAS
    BERNARD, O
    GUGLIELMI, P
    JONVEAUX, P
    CHERIF, D
    GISSELBRECHT, S
    MAUCHAUFFE, M
    BERGER, R
    LARSEN, CJ
    MATHIEUMAHUL, D
    [J]. GENES CHROMOSOMES & CANCER, 1990, 1 (03) : 194 - 208
  • [6] A 3RD TAL-1 PROMOTER IS SPECIFICALLY USED IN HUMAN T-CELL LEUKEMIAS
    BERNARD, O
    AZOGUI, O
    LECOINTE, N
    MUGNERET, F
    BERGER, R
    LARSEN, CJ
    MATHIEUMAHUL, D
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (04) : 919 - 925
  • [7] BERNARD O, 1991, ONCOGENE, V6, P1477
  • [8] HA-RAS AUGMENTS C-JUN ACTIVITY AND STIMULATES PHOSPHORYLATION OF ITS ACTIVATION DOMAIN
    BINETRUY, B
    SMEAL, T
    KARIN, M
    [J]. NATURE, 1991, 351 (6322) : 122 - 127
  • [9] BLENIS J, 1991, CANCER CELL-MON REV, V3, P445
  • [10] BOHMANN D, 1990, CANCER CELL-MON REV, V2, P337